ReviewJournal of family medicine and primary care2026
The effect of fasting Ramadan on type 2 diabetes: A narrative review and practice update.
Review in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Ramadan fasting on glycemic control and lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of clinical studies.Journal of Yeungnam medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ramadan fasting, observed by Muslims worldwide for over 1,400 years, involves abstaining from food, drink, and other physical needs from dawn to sunset. Despite exemptions for individuals with chronic conditions, many patients with type 2 diabetes mellitus (T2DM) choose to fast, raising concerns regarding safety and metabolic control. To synthesize recent literature (2021-2024) on the physiological impact of Ramadan fasting on individuals with T2DM and offer evidence-based recommendations for safe fasting practices. This narrative review evaluates recent clinical studies on the effects of Ramadan fasting in T2DM patients. Key areas include metabolic outcomes, potential risks, and strategies for pre-Ramadan assessment and individualized care. Emerging evidence suggests that Ramadan fasting may offer metabolic benefits to T2DM patients, including improved insulin sensitivity, reductions in body weight, fat mass, blood pressure, and proinflammatory cytokines. Positive changes in gut microbiota and hormonal regulation have also been reported. However, without proper medical oversight, fasting may increase the risk of hypoglycemia, hyperglycemia, dehydration, and diabetic ketoacidosis. The physiological mechanisms of Ramadan fasting align with those of nonreligious intermittent fasting, which also show favorable outcomes in glucose and lipid regulation. Ramadan fasting can be safe and beneficial for many with T2DM when properly managed. Pre-Ramadan planning-including risk assessment, medication adjustments, and education-should begin 6-8 weeks in advance to reduce risks and guide informed decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.